Feb 16, 2021 / 01:00PM GMT
Operator
Good morning, and welcome to the Baudax Bio full-year 2020 financial results conference call. (Operator Instructions) As a reminder, this conference is being recorded at the company's request. I would now like to turn the call over to Ms. Claudia Styslinger, Investor Relations. Ma'am, you may begin.
Claudia Styslinger - Argot Partners, LLC - SVP
Good morning and thank you for joining us on today's conference call to discuss Baudax Bio's full-year 2020 financial results. This is Claudia Styslinger, and I am joined today by Gerri Henwood, President and Chief Executive Officer; John Harlow, Chief Commercial Officer; and Ryan Lake, Chief Financial Officer.
On today's call, Gerri will provide some introductory remarks and business update, John will discuss the progress made on the commercial launch of ANJESO, and Ryan will discuss the financial highlights. Following today's prepared remarks from Gerri, John, and Ryan, we will open the call for questions.
Earlier this morning, we issued a press release detailing our financial results for the full
Q4 2020 Baudax Bio Inc Earnings Call Transcript
Feb 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers